ORGANIC PLANT HEALTH INC.

CIK:0001517248|SEC Filings

Note 12 - Loss Per Share: Schedule of Calculation of Numerator and Denominator in Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2012

Schedule of Calculation of Numerator and Denominator in Earnings Per Share

	For the Years Ended December 31,
	2012			2011

Numerator: Net loss	$	(1,401,300	)	$	(469,990
Denominator: Weighted average common shares outstanding		1,392,824			1,021,179
Basic net loss per share	$	(1.01	)		(0.46	)

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net loss	$ (1,401,300)	$ (469,990)
Adjustments to reconcile net loss to net cash used by operating activities:
Bad debt expense	(1,830)	2,720
Depreciation	29,873	30,109
Amortization of discount to note payable	123,644	50,000
Common stock issued for services rendered	840,183	75,000
Note payable issued for services rendered	75,137
Derivative expenses	108,930
Changes in derivative liabilities	(80,813)	0
Changes in assets and liabilities:
Accounts receivable	13,360	(43,470)
Inventory	(20,751)	87,380
Accounts payable	148,331	(97,244)
Accrued expenses	(7,004)	15,531
Accrued interest	36,433	13,034
Accrued interest - related parties	11,632
Customer deposits	24,905
Common stock to be issued		32,500
Deferred revenues	(55,129)	37,212
Net cash (used in) operating activities	(154,672)	(267,218)
Cash flows from investing activities:
Security deposits	(6,000)
Purchase of property and equipment		(303)
Net cash (used in) investing activities	(6,000)	(303)
Cash flows from financing activities:
Proceeds from notes payable - related parties		42,500
Payments to notes payable - related parties	(10,000)	(22,500)
Proceeds from notes payable	107,500	140,000
Payments to notes payable	(48,893)	(61,935)
Proceeds from stock issuance	94,200	205,482
Net cash provided by financing activities	142,807	303,547
Net increase (decrease) in cash and cash equivalents	(17,865)	36,026
Cash and cash equivalents, beginning of period	42,651	6,625
Cash and cash equivalents, end of period	24,786	42,651
Supplemental cash flow activity:
Cash paid for interest	15,911	12,536
Cash paid for income taxes
Supplemental non-cash investing and financing activity:
Common stock issued to settle accounts payable	17,952	68,245
Note payable created in connection with settlement with former member		101,758
Common stock issued for note conversion	54,500
Common stock issued for accrued interest	1,700
Common stock issued for stock payable	32,500
Note payable issued for prepaid expense	29,863
Common stock issued for deferred compensation	147,317
Debt discount recorded related to convertible notes payable	$ 212,500

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2012	Dec. 31, 2011
Current assets
Cash and cash equivalents	$ 24,786	$ 42,651
Accounts receivable, net	37,433	48,963
Inventory	59,563	38,812
Prepaid expenses	29,863
Total current assets	151,645	130,426
Property and equipment, net	76,904	106,774
Other Assets
Security deposits	12,700	6,700
Total other assets	12,700	6,700
Total Assets	241,249	243,900
Current liabilities
Accounts payable	329,474	199,094
Notes payable - current portion, net of discount	207,879	103,310
Notes payable - related parties	106,684	116,684
Derivative liability	240,617	0
Accrued expenses	23,781	30,786
Accrued interest	40,973	6,240
Accrued interest - related parties	35,259	23,897
Customer deposits	24,905
Common stock to be issued		32,500
Deferred revenues		55,129
Total current liabilities	1,009,572	567,640
Long-term liabilities
Notes payable, net of discount	67,910	152,227
Notes payable - related parties	42,500	42,500
Total long-term liabilities	110,410	194,727
Total liabilities	1,119,982	762,367
Stockholders' deficit
Common stock, par value $0.001; 150,000,000 shares authorized; 1,631,003 and 1,224,296 shares issued and outstanding as of December 31, 2012 and 2011, respectively	1,631	1,224
Preferred stock, par value $0.001; 5,000,000 shares authorized; none of shares issued and outstanding as of December 31, 2012 and 2011, respectively
Deferred compensation	(147,317)
Paid-in capital	1,919,689	731,745
Accumulated deficit	(2,652,736)	(1,251,436)
Total stockholders' deficit	(878,733)	(518,467)
Total liabilities and stockholders' deficit	$ 241,249	$ 243,900